Thalidomide's ability to augment the synthesis of IL-2 in vitro in HIV-infected patients is associated with the percentage of CD4+ cells in their blood

Authors: Shannon E.; Aseffa A.; Pankey G.; Sandoval F.; Lutz B.

Source: Immunopharmacology, Volume 46, Number 2, February 2000 , pp. 175-179(5)

Publisher: Elsevier

Keywords: Thalidomide; Interleukin-2; TNF-; HIV-infected patients

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0162-3109(99)00169-1

Affiliations: 1: Gillis W. Long Hansen's Dis. Ctr. Lab, Research Branch at Louisianna State University, Baton Rouge, LA, USA

Publication date: 2000-02-01

• In this: publication
• By this: publisher
• In this Subject: Microbiology ,  Allergy & Immunology ,  Pharmacology
• By this author: Shannon E. ;  Aseffa A. ;  Pankey G. ;  Sandoval F. ;  Lutz B.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers